As such, apart from glycemic control, other recognized clinical benefits of GLP-1 RAs have been highlighted, including reduction in weight and adiposity, improved blood pressure, and post-prandial excursions of triglycerides and apolipoprotein B, and perhaps reduction in some other diabetes-associated complications (for instance, renal disease) [60,61]. The gene discussed is GCG; the disease is kidney disorder.